Advisory Services Network, LLC Cerus Corp Transaction History

Advisory Services Network, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$3.38 - $4.22 $4,667 - $5,827	1,381 New	1,381 $5,000
Q2 2019 Aug 01, 2019	SELL	$4.51 - $6.6 $69,959 - $102,379	-15,512 Closed	0 $0
Q1 2019 May 20, 2019	SELL	$5.16 - $6.85 $2,523 - $3,349	-489 Reduced 3.06%	15,512 $97,000
Q4 2018 Feb 15, 2019	SELL	$4.89 - $7.16 $2,445 - $3,580	-500 Reduced 3.03%	16,001 $81,000
Q3 2018 Nov 02, 2018	SELL	$6.89 - $7.78 $3,644 - $4,115	-529 Reduced 3.11%	16,501 $119,000
Q2 2018 Jul 27, 2018	BUY	$5.19 - $7.25 $88,385 - $123,467	17,030 New	17,030 $130,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $331M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.